How health workers in DR Congo are treating Ebola and staying safe

There are currently no approved drugs that target Bundibugyo - the species of Ebola responsible for this outbreak.

As Ebola Spreads, Scientists Race to Find Vaccines and Treatments

The Bundibugyo virus, a little known type, previously had caused just two small outbreaks. Now it’s at the center of a rapidly widening epidemic in Africa.

By Carl Zimmer

Ebola outbreak in Africa 'likely far worse' than official figures suggest, IRC warns

Gavi commits $50mn to support the response to Bundibugyo Ebola

Gavi will allocate up to $50 million to combat the Bundibugyo ebola outbreak, focusing on vaccine development and outbreak response efforts.

Moderna and other groups get $60 million to develop Ebola vaccine

Global health organization CEPI will give roughly $60 million to Moderna and two other groups to ‌accelerate the development of shots against Ebola Bundibugyo, the deadly virus that has swept through eastern Congo. The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic. Richard Hatchett, head of CEPI, told Reuters on Monday it was ‌possible to get Ebola Bundibugyo (BDBV) vaccines ready for trials

By The Korea Herald

Moderna and other groups get $60 million to develop Ebola vaccine

Richard Hatchett, head of CEPI, said that it was possible to get Ebola Bundibugyo (BDBV) vaccines ready for trials within a couple of months.

Commentary: The most concerning outbreak right now isn’t Ebola or hantavirus

Despite being the leading cause of vaccine-preventable child deaths worldwide, measles doesn’t garner much attention, says Hsu Li Yang of the Saw Swee Hock School of Public Health.

Emerging viruses

After the devastating Covid-19 pandemic, most people believe their lives have returned to normal. However, several recent outbreaks such as Ebola, Nipah virus, Hantavirus, mpox (monkeypox) and avian influenza, are under strict surveillance by global health agencies to reduce the risk of another pandemic.

Mexico bars travelers from 3 African nations over Ebola fears ahead of World Cup

International travelers — excluding Mexican nationals and residents — who have been in Uganda, the Democratic Republic of the Congo or South Sudan in the last 21 days are currently barred from entering Mexico. The post Mexico bars travelers from 3 African nations over Ebola fears ahead of World Cup appeared first on Mexico News Daily

By MND Staff

Merck exec says company is discussing use of COVID antiviral drug in Ebola response

Merck is in discussions with various global health authorities about making its COVID antiviral pill, molnupiravir, available as an Ebola treatment to address the widening outbreak in the Democratic Republic of Congo, a senior executive told Reuters.

By Abubakar Ibrahim